Post- Exposure Prophylaxis

Dr Robert Hess: In case of Covid-19 infection – overview of current MAB treatment options.

Dr Robert Hess: In case of Covid-19 infection – overview of current MAB treatment options. Currently, three anti-SARS-CoV-2 MAB products have received Emergency Use Authorization (EUA) from the FDA for the treatment of mild to moderate COVID-19 in non-hospitalized patients with laboratory-confirmed SARS-CoV-2 infection who are at high risk for progressing to severe disease and/or…

Read More